The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1559
ISSUE1559
November 5, 2018
Cannabidiol (Epidiolex) for Epilepsy
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Cannabidiol (Epidiolex) for Epilepsy
November 5, 2018 (Issue: 1559)
The FDA has approved cannabidiol oral solution
(Epidiolex – Greenwich Biosciences) for treatment
of seizures associated with Dravet syndrome or
Lennox-Gastaut syndrome in patients ≥2 years old.
Cannabidiol (CBD) is a cannabinoid constituent...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.